358 related articles for article (PubMed ID: 21184860)
1. The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.
Yadav VR; Prasad S; Sung B; Aggarwal BB
Int Immunopharmacol; 2011 Mar; 11(3):295-309. PubMed ID: 21184860
[TBL] [Abstract][Full Text] [Related]
2. Promising anti-inflammatory effects of chalcones via inhibition of cyclooxygenase, prostaglandin E
Ur Rashid H; Xu Y; Ahmad N; Muhammad Y; Wang L
Bioorg Chem; 2019 Jun; 87():335-365. PubMed ID: 30921740
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of 4-hydroxyderricin and xanthoangelol on lipopolysaccharide-induced inflammatory responses in RAW264 macrophages.
Yasuda M; Kawabata K; Miyashita M; Okumura M; Yamamoto N; Takahashi M; Ashida H; Ohigashi H
J Agric Food Chem; 2014 Jan; 62(2):462-7. PubMed ID: 24369884
[TBL] [Abstract][Full Text] [Related]
4. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
[TBL] [Abstract][Full Text] [Related]
5. Cardamonin attenuates chronic inflammation and tumorigenesis in colon.
Hou S; Yuan Q; Yu N; Liu B; Huang G; Yuan X
Cell Cycle; 2019 Dec; 18(23):3275-3287. PubMed ID: 31570032
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of the flavonoid hesperidin methyl chalcone in inflammation and pain in mice: role of TRPV1, oxidative stress, cytokines and NF-κB.
Pinho-Ribeiro FA; Hohmann MS; Borghi SM; Zarpelon AC; Guazelli CF; Manchope MF; Casagrande R; Verri WA
Chem Biol Interact; 2015 Feb; 228():88-99. PubMed ID: 25617481
[TBL] [Abstract][Full Text] [Related]
7. Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells.
Moon DO; Choi YH; Moon SK; Kim WJ; Kim GY
Toxicol In Vitro; 2010 Oct; 24(7):1927-34. PubMed ID: 20696233
[TBL] [Abstract][Full Text] [Related]
8. Butein inhibits NF-κB activation and reduces infiltration of inflammatory cells and apoptosis after spinal cord injury in rats.
Lu M; Wang S; Han X; Lv D
Neurosci Lett; 2013 May; 542():87-91. PubMed ID: 23499960
[TBL] [Abstract][Full Text] [Related]
9. 2',4-Dihydroxy-3',4',6'-trimethoxychalcone from Chromolaena odorata possesses anti-inflammatory effects via inhibition of NF-κB and p38 MAPK in lipopolysaccharide-activated RAW 264.7 macrophages.
Dhar R; Kimseng R; Chokchaisiri R; Hiransai P; Utaipan T; Suksamrarn A; Chunglok W
Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):43-51. PubMed ID: 29199487
[TBL] [Abstract][Full Text] [Related]
10. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
11. Design and Discovery of Some Novel Chalcones as Antioxidant and Anti-Inflammatory Agents via Attenuating NF-κB.
Chu J; Guo CL
Arch Pharm (Weinheim); 2016 Jan; 349(1):63-70. PubMed ID: 26660296
[TBL] [Abstract][Full Text] [Related]
12. Trends in utilization of the pharmacological potential of chalcones.
Batovska DI; Todorova IT
Curr Clin Pharmacol; 2010 Feb; 5(1):1-29. PubMed ID: 19891604
[TBL] [Abstract][Full Text] [Related]
13. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer.
Prasad S; Phromnoi K; Yadav VR; Chaturvedi MM; Aggarwal BB
Planta Med; 2010 Aug; 76(11):1044-63. PubMed ID: 20635307
[TBL] [Abstract][Full Text] [Related]
14. Recent trends of chalcones potentialities as antiproliferative and antiresistance agents.
Winter E; Locatelli C; Di Pietro A; Creczynski-Pasa TB
Anticancer Agents Med Chem; 2015; 15(5):592-604. PubMed ID: 25553434
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of methoxyphenyl- and coumarin-based chalcone derivatives as anti-inflammatory agents by inhibition of NO production and down-regulation of NF-κB in LPS-induced RAW264.7 macrophage cells.
Emam SH; Sonousi A; Osman EO; Hwang D; Kim GD; Hassan RA
Bioorg Chem; 2021 Feb; 107():104630. PubMed ID: 33476864
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of adipocyte inflammation and macrophage chemotaxis by butein.
Wang Z; Lee Y; Eun JS; Bae EJ
Eur J Pharmacol; 2014 Sep; 738():40-8. PubMed ID: 24877688
[TBL] [Abstract][Full Text] [Related]
17. The importance of natural chalcones in ischemic organ damage: Comprehensive and bioinformatic analysis review.
Sayed AM; Gohar OM; Abd-Alhameed EK; Hassanein EHM; Ali FEM
J Food Biochem; 2022 Oct; 46(10):e14320. PubMed ID: 35857486
[TBL] [Abstract][Full Text] [Related]
18. Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro.
Qin Y; Sun CY; Lu FR; Shu XR; Yang D; Chen L; She XM; Gregg NM; Guo T; Hu Y
Leuk Res; 2012 Apr; 36(4):514-20. PubMed ID: 22226224
[TBL] [Abstract][Full Text] [Related]
19. Novel dual-targeting anti-proliferative dihydrotriazine-chalcone derivatives display suppression of cancer cell invasion and inflammation by inhibiting the NF-κB signaling pathway.
Gan FF; Zhang R; Ng HL; Karuppasamy M; Seah W; Yeap WH; Ong SM; Hadadi E; Wong SC; Chui WK; Chew EH
Food Chem Toxicol; 2018 Jun; 116(Pt B):238-248. PubMed ID: 29630947
[TBL] [Abstract][Full Text] [Related]
20. Potential of butein, a tetrahydroxychalcone to obliterate cancer.
Padmavathi G; Rathnakaram SR; Monisha J; Bordoloi D; Roy NK; Kunnumakkara AB
Phytomedicine; 2015 Dec; 22(13):1163-71. PubMed ID: 26598915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
